Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review

There are currently no pharmacological treatments available that completely halt or reverse the progression of Parkinson’s Disease (PD). Hence, there is an unmet need for neuroprotective therapies. Lewy bodies are a neuropathological hallmark of PD and contain aggregated α-synuclein (α-syn) which is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodger, Abbie T., ALNasser, Maryam, Carter, Wayne G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341763/
https://www.ncbi.nlm.nih.gov/pubmed/37446200
http://dx.doi.org/10.3390/ijms241311022

Ejemplares similares

Ejemplares similares